Characteristics | Total no. | Taxane-based group | Non-taxane-based group | P |
---|---|---|---|---|
Total no. | 110 | 58 | 52 | |
Median age (range) | 54 (21–76) | 54 (30–76) | 54 (21–73) | |
Age (years) | 0.437 | |||
<65 | 94 | 51 | 43 | |
≥65 | 16 | 7 | 9 | |
Histotype | 0.095 | |||
Serous | 84 | 48 | 36 | |
Othersa | 26 | 10 | 16 | |
Grade | 0.120 | |||
G1-2 | 38 | 21 | 17 | |
G3 | 72 | 37 | 35 | |
Ascites (mL) | 0.193 | |||
<1000 | 67 | 32 | 35 | |
≥1000 | 43 | 26 | 17 | |
Residual tumor at surgery (cm) | 0.513 | |||
<1 | 43 | 21 | 22 | |
≥1 | 67 | 37 | 30 | |
Median cycle of chemotherapy (range) | 6 (2–8) | 6 (2–8) | 6 (2–8) |